Get Real Time Here
| Open29.460 | Close- |
| Vol / Avg.213.227K / 798.605K | Mkt Cap1.710B |
| Day Range29.060 - 29.930 | 52 Wk Range18.611 - 61.940 |
Harmony Biosciences Stock (NASDAQ:HRMY), Quotes and News Summary
Harmony Biosciences Stock (NASDAQ: HRMY) stock price, news, charts, stock research, profile.
| Open29.460 | Close- |
| Vol / Avg.213.227K / 798.605K | Mkt Cap1.710B |
| Day Range29.060 - 29.930 | 52 Wk Range18.611 - 61.940 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.650 | 0.970 | 0.3200 | ||||
| REV | 148.870M | 160.268M | 11.398M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-01 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 53.00 |
| 2023-11-01 | Raymond James | Danielle Brill | Maintains | OutperformOutperform | Raises | 26.00 | 27.00 |
| 2023-10-16 | Piper Sandler | David Amsellem | Maintains | OverweightOverweight | Lowers | 72.00 | 42.00 |
| 2023-10-16 | Needham | Ami Fadia | Maintains | BuyBuy | Lowers | 66.00 | 53.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HRMY | Harmony Biosciences | 0% | 1.7B |
| VRNA | Verona Pharma | 3.97% | 1.1B |
| SUPN | Supernus Pharmaceuticals | 0% | 1.5B |
| CBAY | CymaBay Therapeutics | 3.46% | 2.2B |
| NMRA | Neumora Therapeutics | -1.07% | 1.8B |
How do I buy Harmony Biosciences (HRMY) stock?
You can purchase shares of Harmony Biosciences (NASDAQ: HRMY) through any online brokerage.
Who are Harmony Biosciences's (HRMY) competitors?
Other companies in Harmony Biosciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), CymaBay Therapeutics (NASDAQ:CBAY), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
What is the target price for Harmony Biosciences (HRMY) stock?
The latest price target for Harmony Biosciences (NASDAQ: HRMY) was reported by Needham on Wednesday, November 1, 2023. The analyst firm set a price target for 53.00 expecting HRMY to rise to within 12 months (a possible 80.27% upside). 34 analyst firms have reported ratings in the last year.
Current Stock Price for Harmony Biosciences (HRMY)?
The stock price for Harmony Biosciences (NASDAQ: HRMY) is $29.4 last updated November 29, 2023 at 9:00 PM UTC.
Does Harmony Biosciences (HRMY) pay a dividend?
There is no dividend information for Harmony Biosciences.
When is Harmony Biosciences (NASDAQ:HRMY) reporting earnings?
Harmony Biosciences’s Q4 earnings are confirmed for Tuesday, February 20, 2024.
Is Harmony Biosciences (HRMY) going to split?
There is no upcoming split for Harmony Biosciences.
What sector and industry does Harmony Biosciences (HRMY) operate in?
Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.